Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice.
antidepressant
bile acids
metabolomics
microbiome
paroxetine
Journal
Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
10
2019
accepted:
20
05
2020
entrez:
26
6
2020
pubmed:
26
6
2020
medline:
26
6
2020
Statut:
epublish
Résumé
Recent interest in the role of microbiota in health and disease has implicated gut microbiota dysbiosis in psychiatric disorders including major depressive disorder. Several antidepressant drugs that belong to the class of selective serotonin reuptake inhibitors have been found to display antimicrobial activities. In fact, one of the first antidepressants discovered serendipitously in the 1950s, the monoamine-oxidase inhibitor Iproniazid, was a drug used for the treatment of tuberculosis. In the current study we chronically treated DBA/2J mice for 2 weeks with paroxetine, a selective serotonin reuptake inhibitor, and collected fecal pellets as a proxy for the gut microbiota from the animals after 7 and 14 days. Behavioral testing with the forced swim test revealed significant differences between paroxetine- and vehicle-treated mice. Untargeted mass spectrometry and 16S rRNA profiling of fecal pellet extracts showed several primary and secondary bile acid level, and microbiota alpha diversity differences, respectively between paroxetine- and vehicle-treated mice, suggesting that microbiota functions are altered by the drug. In addition to their lipid absorbing activities bile acids have important signaling activities and have been associated with gastrointestinal diseases and colorectal cancer. Antidepressant drugs like paroxetine should therefore be used with caution to prevent undesirable side effects.
Identifiants
pubmed: 32581888
doi: 10.3389/fpsyt.2020.00518
pmc: PMC7287167
doi:
Types de publication
Journal Article
Langues
eng
Pagination
518Informations de copyright
Copyright © 2020 Dethloff, Vargas, Elijah, Quinn, Park, Herzog, Müller, Gentry, Knight, Gonzalez, Dorrestein and Turck.
Références
Psychopharmacology (Berl). 2008 Nov;200(4):557-72
pubmed: 18629477
J Lipid Res. 2009 Aug;50(8):1509-20
pubmed: 19346331
J Affect Disord. 2017 Jan 15;208:22-32
pubmed: 27744123
Cell Metab. 2013 May 7;17(5):657-69
pubmed: 23602448
Front Microbiol. 2014 Apr 07;5:146
pubmed: 24778631
Gut. 2013 Apr;62(4):531-9
pubmed: 22993202
Anal Chem. 2017 Sep 5;89(17):8696-8703
pubmed: 28752754
Mol Endocrinol. 2014 Aug;28(8):1221-38
pubmed: 24892638
Gut Microbes. 2014 May-Jun;5(3):369-80
pubmed: 24685620
J Gastroenterol Hepatol. 2016 Dec;31(12):1946-1955
pubmed: 27037739
Annu Rev Biochem. 2003;72:137-74
pubmed: 12543708
Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
Sci Rep. 2016 Oct 12;6:35317
pubmed: 27731396
Neurogastroenterol Motil. 2016 Sep;28(9):1330-40
pubmed: 27060367
Biol Psychiatry. 2017 Mar 1;81(5):e35-e37
pubmed: 28137375
Psychopharmacology (Berl). 2019 May;236(5):1411-1432
pubmed: 30806744
Cell. 2019 May 30;177(6):1600-1618.e17
pubmed: 31150625
Genes Brain Behav. 2014 Jan;13(1):69-86
pubmed: 24286462
Brain Behav Immun. 2015 Aug;48:186-94
pubmed: 25882912
Adv Nutr. 2013 Jan 01;4(1):29-35
pubmed: 23319120
Nature. 2019 Oct;574(7779):543-548
pubmed: 31645720
Toxicol Appl Pharmacol. 2019 Jan 15;363:79-87
pubmed: 30502395
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4523-30
pubmed: 20837534
Transl Psychiatry. 2019 Sep 13;9(1):223
pubmed: 31519869
J Neurosci. 2014 Nov 12;34(46):15490-6
pubmed: 25392516
Mol Psychiatry. 2016 Jun;21(6):797-805
pubmed: 27090302
Annu Rev Neurosci. 2017 Jul 25;40:21-49
pubmed: 28301775
Nat Rev Neurosci. 2012 Oct;13(10):701-12
pubmed: 22968153
Cell Host Microbe. 2015 May 13;17(5):565-76
pubmed: 25974299
Nat Rev Microbiol. 2012 Nov;10(11):735-42
pubmed: 23000955
Mol Psychiatry. 2016 Jun;21(6):786-96
pubmed: 27067014
Cell Signal. 2008 Dec;20(12):2180-97
pubmed: 18634871
Int J Syst Evol Microbiol. 2000 May;50 Pt 3:971-978
pubmed: 10843034
Genome Med. 2016 Apr 06;8(1):36
pubmed: 27048547
Int J Syst Evol Microbiol. 2001 Jan;51(Pt 1):39-44
pubmed: 11211270
PLoS Biol. 2017 Dec 28;15(12):e2002690
pubmed: 29283992
Frontline Gastroenterol. 2014 Jan;5(1):49-57
pubmed: 28839751
Transl Psychiatry. 2011 Dec 13;1:e58
pubmed: 22832350
Cell. 2019 Feb 21;176(5):1098-1112.e18
pubmed: 30794774
Nat Methods. 2018 Oct;15(10):796-798
pubmed: 30275573
Nat Rev Drug Discov. 2008 Aug;7(8):678-93
pubmed: 18670431
mSphere. 2016 Jan 06;1(1):
pubmed: 27239562
Curr Opin Gastroenterol. 2014 May;30(3):332-8
pubmed: 24625896
Int J Antimicrob Agents. 2000 Apr;14(3):177-80
pubmed: 10773485
J Affect Disord. 2016 Sep 15;202:254-7
pubmed: 27288567
J Clin Psychiatry. 2000 Jun;61(6):403-8
pubmed: 10901336
Am J Pathol. 2011 Jan;178(1):175-86
pubmed: 21224055
Gastroenterology. 2014 May;146(6):1525-33
pubmed: 24560870
Neurogastroenterol Motil. 2013 Sep;25(9):713-9
pubmed: 23910373
Am J Psychiatry. 2006 Jan;163(1):28-40
pubmed: 16390886
Transl Psychiatry. 2017 Apr 4;7(4):e1078
pubmed: 28375208
PLoS Pathog. 2013;9(11):e1003726
pubmed: 24244158
Appl Environ Microbiol. 2005 Dec;71(12):8228-35
pubmed: 16332807
Nature. 2020 Mar;579(7797):123-129
pubmed: 32103176
Toxicol Sci. 2009 Apr;108(2):225-46
pubmed: 19131563
Acta Pharm Sin B. 2015 Mar;5(2):99-105
pubmed: 26579434
Expert Opin Biol Ther. 2014 Apr;14(4):467-82
pubmed: 24479734
Sci Rep. 2017 Apr 03;7:45942
pubmed: 28368029
J Psychiatr Res. 2013 Mar;47(3):289-98
pubmed: 23207114
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Adv Exp Med Biol. 2014;817:115-33
pubmed: 24997031
Neurogastroenterol Motil. 2011 Mar;23(3):255-64, e119
pubmed: 21054680
Expert Rev Gastroenterol Hepatol. 2014 Jan;8(1):49-61
pubmed: 24410472
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
BMC Bioinformatics. 2010 Jul 23;11:395
pubmed: 20650010
J Clin Invest. 2011 Jan;121(1):86-95
pubmed: 21123943